The Food and Drug Administration is currently considering MDMA as a treatment for post-traumatic stress disorder. Anna Silman, features correspondent at Business Insider, breaks down her reporting on the decades-long fight to legalize the drug and why some pro-MDMA advocates are sounding the alarm.
